FDA'S MEDWATCH SAFETY ALERTS: JANUARY 2013

Printer-friendly versionPrinter-friendly version Share this

March 2, 2013 (Washington, D.C.) – The Food and Drug Administration (FDA) has recently issued alerts or other safety information about a number of products, including metal-on-metal hip implants, which release metal particles into the bloodstream, sleep drugs that reduce morning alertness—especially in women, and a motion sickness drug packaged in error as an iron supplement.

These and other alerts were prompted by reports FDA received from health care professionals and the public through the agency’s MedWatch Adverse Event Reporting Program.

Read this Consumer Update to learn more about these safety alerts and what to do if you’ve used one of the products described.